Abstract:Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with high prevalence and mortality. In some acute exacerbations of COPD (AECOPD) in patients with no obvious signs of infection, early antibiotic treatment seems to clinically improve the disease, but more studies are needed to determine the prognostic impact of antibiotic treatment in AECOPD patients with no obvious signs of infection. Purpose: To clarify the impact of antibiotic treatment on the short-term and long-term prognoses of AECOPD patients without obvious signs of infection. Methods: The impact of the two treatment methods on the prognosis of patients was compared at 30, 90, 180, and 360 days after discharge. A multicenter, randomized, parallel-controlled clinical trial was conducted in a department of respiratory and critical care medicine in Central China. All patients met the inclusion criteria for AECOPD, and the patients were randomly assigned to the antibiotic group or the nonantibiotic group at a 1:1 ratio. Patients in the antibiotic group were given moxifloxacin 400 mg/day intravenously for 7 days. Patients in the nonantibiotic group were intravenously injected with the same amount of normal saline as the amount of moxifloxacin given to those in the antibiotic group for 7 days. Results: There were 406 patients in the antibiotic group and 410 patients in the nonantibiotic group. During the short-term and long-term follow-ups, the acute exacerbation frequency, intensive care unit (ICU) treatment rate, mortality, and mMRC and CAT scores were not significantly different between the two groups ( p > 0.05). At the 180- and 360-day follow-ups, the forced expiratory volume in 1 s (FEV1%) and peak expiratory flow (PEF) were not significantly different between the two groups ( p > 0.05). The 30-day readmission rate was significantly lower in the antibiotic group than in the nonantibiotic group ( p < 0.05). The time from discharge to the first acute exacerbation was not significantly different between the two groups ( p > 0.05). The length of the first hospital stay after discharge was significantly lower in the antibiotic group (5.84 days) than in the nonantibiotic group (6.75 days) ( p < 0.05). At the 30-day follow-up, the acute exacerbation frequency, age, C-reactive protein (CRP) level, and sputum viscosity were significantly greater in the nonantibiotic group than in the antibiotic group ( p 62.5 years, with a CRP level >12.56 mg/L or with a sputum viscosity >III, in the nonantibiotic group than in those in the antibiotic group, suggesting that the short-term prognosis was poor. Conclusion: Patients who are >62.5 years of age, have a CRP concentration >12.56 mg/L, or have a sputum viscosity >III without obvious signs of infection should be treated with antibiotics to improve their short-term prognosis. Clinical Trial Registration:: (https://www.chictr.org.cn), (ChiCTR1800018921)

A Comparison Stuty of Acute Exacerbations of COPD with Two Different Period Treatments of Antibacterial

Value of Procalcitonin in Guiding the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Cost-effectiveness Analysis of 2 Schemes for Bacterial Infections of Acute Exacerbation of Severe COPD

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

Short-term and Long-Term Outcomes of Moxifloxacin Treatment in Acute Exacerbations of COPD

Efficacy of β2-agonist and Impratropium Bromide in Chronic Obstructive Pulmonary Disease

Clinical effects observation of BiPAP combined with inhalation Terbutaline plus Ambroxol in the treatment of AECOPD patients with type Ⅱ respiratory failure

Clinical Efficacy Observation of Acetylcysteine Combined with Tiotropium Bromide Inhalation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Effectiveness of pulmicort respules combined with combivent treating acute exacerbation of chronic obstructive pulmonary disease: a Meta analysis

Yiqi Huoxue Huatan Method with Noninvasive Assisted Ventilation Therapy Acute Exacerbations of Copd Curative Effect Observation of Respiratory Failure

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

Comparison of Effect of Budesonide and Systemic Corticosteroids on Acute Exacerbations of COPD:A Meta-analysis

Effect of integrative Chinese and western medicine on acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure

Use of antibacterial agents in acute exacerbation of chronic obstructive pulmonary disease——Interpretation of COPD guidelines

Chronic Obstructive Pulmonary Disease with Acute Aggravating Period of Etiology and Drug Resistance Analysis

The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis.

Comparison Of The Clinical Outcomes Between Nebulized And Systemic Corticosteroids In The Treatment Of Acute Exacerbation Of Copd In China (Contain Study): A Post Hoc Analysis

Different dose of ambroxol on acute exacerbation of chronic obstructive pulmonary disease in elderly patients

Changes of procalcitonin and C-reactive protein in acute phase of chronic obstructive pulmonary disease and its si nificance

The Effects of Non-Invasive Ventilator in Treatment with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes Before and after Treatment of AECOPD, a Longitudinal and Cross-Sectional Study.